ABSTRACT
Immunobiological properties of human specific transfer factor (TF) to Staphylococcus aureus antigens were studied. It is shown that this TF activated human leucocytes in vitro as well as in vivo. Antigen specificity of TF's immunomodulating effects is also shown. In vitro we used leucocyte migration inhibition test (IML), macrophage inhibition test (MPI) and rosette formation (E-ros). For testing in vivo we used delayed type hypersensitivity (DTH) skin tests.
Subject(s)
Antigens, Bacterial/immunology , Staphylococcus aureus/immunology , Transfer Factor/immunology , Animals , Blood Donors , Cell Migration Inhibition , Epitopes/drug effects , Epitopes/immunology , Guinea Pigs , Humans , Hypersensitivity, Delayed/immunology , Immunization/methods , Lymphocyte Activation/drug effects , Lymphocyte Activation/immunology , Rosette Formation , Species Specificity , Staphylococcal Protein A/immunology , Transfer Factor/pharmacologyABSTRACT
Today's statement of transfer factor, an immunostimulator derived from leukocytes which enhances antiinfectious immunity, is observed in the review. Basic biological, physical and chemical characteristics of the transfer factor, its possible action mechanisms, and laboratory and clinical methods of use to cure infectious fungal (Candida, Coccidium), invasive (schistosomiasis, leishmaniasis, cryptosporidiosis), viral (varicella zoster, ophthalmic herpes, Herpes simplex types 1 and 2, H. zoster, H. simplex ceratitis, genital herpes, human herpes virus type 6, postherpetic neuritis, hepatitis B, AIDS), and bacterial infections (Mycobacterium leprae, M. tuberculosis, M. fortuitum, Salmonella cholerae suis, S. dublin, S. Virchov, Brucella abortus, Actinobacillus pleuropneumoniae, bacterial sepsis, Staphylococcus) are described.